Arterial baroreflex dysfunction impairs ischemia-induced angiogenesis

Journal of the American Heart Association

Volumn 3, Issue 3, 2014, Pages

  Hao, Changning ^a,b,c   Huang, Zhen Hao ^c   Song, Shu Wei ^d   Shi, Yi Qin ^c   Cheng, Xian Wu ^a   Murohara, Toyoaki ^a   Lu, Wei ^b   Su, Ding Feng ^d   Duan, Jun Li ^b,c  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHANGHAI INSTITUTE OF TECHNICAL PHYSICS   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acetylcholinesterase inhibitor; Angiogenesis; Arterial baroreflex; Non neural cholinergic system; Peripheral vascular disease

Indexed keywords

ACETYLCHOLINE DERIVATIVE; ACETYLCHOLINESTERASE; ANGIOGENIC FACTOR; BUNGAROTOXIN RECEPTOR; CHOLINERGIC RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NICOTINIC RECEPTOR; PYRIDOSTIGMINE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; CHOLINESTERASE INHIBITOR; HIF1A PROTEIN, RAT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BAROREFLEX DYSFUNCTION; ARTICLE; CAPILLARY DENSITY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DENERVATION; ENZYME INHIBITION; HINDLIMB; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LIMB ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RANDOMIZATION; RAT; REFLEX DISORDER; SHAM PROCEDURE; SIGNAL TRANSDUCTION; SKIN TEMPERATURE; SPRAGUE DAWLEY RAT; ANIMAL; ARTERY; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; ISCHEMIA; LIMB; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSORECEPTOR REFLEX; VASCULARIZATION;

ANIMALS; ARTERIES; BAROREFLEX; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; EXTREMITIES; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIA; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PYRIDOSTIGMINE BROMIDE; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84916203000     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.000804     Document Type: Article

References (37)

1. Aranguren XL, Verfaillie CM, Luttun A. Emerging hurdles in stem cell therapy for peripheral vascular disease. J Mol Med (Berl). 2009;87:3-16.
2. Emanueli C, Madeddu P. Therapeutic angiogenesis: translating experimental concepts to medically relevant goals. Vascul Pharmacol. 2006;45:334-339.
3. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427-435.
4. Kinoshita M, Fujita Y, Katayama M, Baba R, Shibakawa M, Yoshikawa K, Katakami N, Furukawa Y, Tsukie T, Nagano T, Kurimoto Y, Yamasaki K, Handa N, Okada Y, Kuronaka K, Nagata Y, Matsubara Y, Fukushima M, Asahara T, Kawamoto A. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized cd34 positive cells in patients with critical limb ischemia. Atherosclerosis. 2012;224:440-445.
5. Parati G, Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012;33:1058-1066.
6. Lohmeier TE, Iliescu R. Lowering of blood pressure by chronic suppression of central sympathetic outflow: insight from prolonged baroreflex activation. J Appl Physiol. 1985;2012(113):1652-1658.
7. Mortara A, La Rovere MT, Pinna GD, Prpa A, Maestri R, Febo O, Pozzoli M, Opasich C, Tavazzi L. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation. 1997;96:3450-3458.
8. La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, Bigger JT, Jr, Camm AJ, Schwartz PJ. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103:2072-2077.
9. Robinson TG, Dawson SL, Eames PJ, Panerai RB, Potter JF. Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke. 2003;34:705-712.
10. Cai GJ, Miao CY, Xie HH, Lu LH, Su DF. Arterial baroreflex dysfunction promotes atherosclerosis in rats. Atherosclerosis. 2005;183:41-47.
11. Vasquez EC, Peotta VA, Meyrelles SS. Cardiovascular autonomic imbalance and baroreflex dysfunction in the apolipoprotein E-deficient mouse. Cell Physiol Biochem. 2012;29:635-646.
12. Yu JG, Song SW, Shu H, Fan SJ, Liu AJ, Liu C, Guo W, Guo JM, Miao CY, Su DF. Baroreflex deficiency hampers angiogenesis after myocardial infarction via acetylcholine-α7-nicotinic ACh receptor in rats. Eur Heart J. 2011;34:2412-2420.
13. Liu AJ, Guo JM, Xia W, Su DF. New strategies for the prevention of stroke. Clin Exp Pharmacol Physiol. 2010;37:265-271.
14. Duan J, Murohara T, Ikeda H, Katoh A, Shintani S, Sasaki K, Kawata H, Yamamoto N, Imaizumi T. Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. Circulation. 2000;102:370-376.
15. Duan J, Murohara T, Ikeda H, Sasaki K, Shintani S, Akita T, Shimada T, Imaizumi T. Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia. Arterioscler Thromb Vasc Biol. 2000;20:2579-2585.
16. Cheng XW, Kuzuya M, Kim W, Song H, Hu L, Inoue A, Nakamura K, Di Q, Sasaki T, Tsuzuki M, Shi GP, Okumura K, Murohara T. Exercise training stimulates ischemia-induced neovascularization via phosphatidylinositol 3-kinase/Aktdependent hypoxia-induced factor-1 alpha reactivation in mice of advanced age. Circulation. 2010;122:707-716.
17. Yu JG, Zhang EH, Liu AJ, Liu JG, Cai GJ, Su DF. Ketanserin improves cardiac performance after myocardial infarction in spontaneously hypertensive rats partially through restoration of baroreflex function. Acta Pharmacol Sin. 2013;34:1508-1514.
18. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, Cooke JP. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med. 2001;7:833-839.
19. Cooke JP. Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor. Life Sci. 2007;80:2347-2351.
20. Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest. 2002;110:527-536.
21. Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol. 2008;154:1558-1571.
22. Kawashima K, Fujii T. Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. J Pharmacol Sci. 2008;106:167-173.
23. Huang ZH, Guo W, Zhang LL, Song SW, Hao CN, Duan JL. Donepezil protects endothelial cells against hydrogen peroxide-induced cell injury. CNS Neurosci Ther. 2012;18:185-187.
24. Shen FM, Zhang SH, Xie HH, Jing Q, Wang DS, Su DF. Early structural changes of aortic wall in sinoaortic-denervated rats. Clin Exp Pharmacol Physiol. 2006;33:358-363.
25. Feng J, Luo H, Qiu Y, Zhou W, Yu F, Wu F. Down-regulation of DDAH2 and eNOS induces endothelial dysfunction in sinoaortic-denervated rats. Eur J Pharmacol. 2011;661:86-91.
26. Zucker IH, Hackley JF, Cornish KG, Hiser BA, Anderson NR, Kieval R, Irwin ED, Serdar DJ, Peuler JD, Rossing MA. Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension. 2007;50:904-910.
27. Sabbah HN, Gupta RC, Imai M, Irwin ED, Rastogi S, Rossing MA, Kieval RS. Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure. Circ Heart Fail. 2011;4:65-70.
28. Cooke JP, Ghebremariam YT. Endothelial nicotinic acetylcholine receptors and angiogenesis. Trends Cardiovasc Med. 2008;18:247-253.
29. Kakinuma Y, Ando M, Kuwabara M, Katare RG, Okudela K, Kobayashi M, Sato T. Acetylcholine from vagal stimulation protects cardiomyocytes against ischemia and hypoxia involving additive non-hypoxic induction of HIF-1alpha. FEBS Lett. 2005;579:2111-2118.
30. Kakinuma Y, Tsuda M, Okazaki K, Akiyama T, Arikawa M, Noguchi T, Sato T. Heart-specific overexpression of choline acetyltransferase gene protects murine heart against ischemia through hypoxia-inducible factor-1α-related defense mechanisms. J Am Heart Assoc. 2013;2:e004887.
31. Nagy PM, Aubert I. Overexpression of the vesicular acetylcholine transporter increased acetylcholine release in the hippocampus. Neuroscience. 2012;218:1-11.
32. Lataro RM, Silva CA, Fazan R, Jr, Rossi MA, Prado CM, Godinho RO, Salgado HC. Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure. Am J Physiol Regul Integr Comp Physiol. 2013;305:R908-R916.
33. Kirkpatrick CJ, Bittinger F, Unger RE, Kriegsmann J, Kilbinger H, Wessler I. The non-neuronal cholinergic system in the endothelium: evidence and possible pathobiological significance. Jpn J Pharmacol. 2001;85:24-28.
34. Kawashima K, Watanabe N, Oohata H, Fujimoto K, Suzuki T, Ishizaki Y, Morita I, Murota S. Synthesis and release of acetylcholine by cultured bovine arterial endothelial cells. Neurosci Lett. 1990;119:156-158.
35. Kawashima K, Oohata H, Fujimoto K, Suzuki T. Extraneuronal localization of acetylcholine and its release upon nicotinic stimulation in rabbits. Neurosci Lett. 1989;104:336-339.
36. Narimatsu N, Harada N, Kurihara H, Nakagata N, Sobue K, Okajima K. Donepezil improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus. J Pharmacol Exp Ther. 2009;330:2-12.
37. Wu JC, Chruscinski A, De Jesus Perez VA, Singh H, Pitsiouni M, Rabinovitch M, Utz PJ, Cooke JP. Cholinergic modulation of angiogenesis: role of the 7 nicotinic acetylcholine receptor. J Cell Biochem. 2009; 108: 433-446.